TELA Bio | Surgical Reconstruction Company The hernia repair industry is shifting away from dated synthetic mesh—and for good reason Hear from Antony Koblish, TELA Bio Co-founder and Chief Executive Officer, on what inspired the development of OviTex—and what it means for patients
TELA Bio, Inc. (TELA) - Yahoo Finance Find the latest TELA Bio, Inc (TELA) stock quote, history, news and other vital information to help you with your stock trading and investing
TELA Bio (TELA) Stock Price Overview A detailed overview of TELA Bio, Inc (TELA) stock, including real-time price, chart, key statistics, news, and more
TELA Bio (TELA) Stock Price, News Analysis - MarketBeat TELA Bio, Inc (NASDAQ: TELA) is a commercial‐stage medical technology company headquartered in Malvern, Pennsylvania The company is focused on developing, manufacturing and commercializing regenerative medicine and advanced soft tissue repair solutions
TELA Bio, Inc. | Nov. 2025 - canaccordgenuity. com TELA Bio designs, develops and markets innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction The Company is committed to providing patients with advanced, economically effective biologic material repair solutions to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes
TELA - Tela Bio, Inc. Latest Stock News Market Updates TELA Bio, Inc (TELA) is a United States-based commercial-stage medical technology company focused on the development and commercialization of innovative soft tissue reconstruction solutions
News Releases - TELA Bio, Inc. MALVERN, Pa , Aug 11, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the second quarter ended June 30, 2025